No records found

Date Title Press release Webcast Presentation Other
7 Jun 2007 Safinamide - Abstracts from Movement Disorder Society's 11th International Congress, Istanbul PDF
10 May 2007 Safinamide, a New Anti-Parkinson Agent, is Effective and well-tolerated in Early Parkinson’s Disease PD Patients on a Stable Dose of a Single DA-Agonist: Results of a Randomized, International, Placebo-controlled, Phase III Trial PDF
Half Year Report 2022

Download the Half Year Report 2022 below.

Annual Report 2022

Download the Annual Report 2022 below.